Search Results - Duintjer Tebbens, Erik Jurjen

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Are ENT1 /ENT1, NOTCH3, and miR-21 Reliable Prognostic Biomarkers in Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Gemcitabine Monotherapy?

    Are ENT1 /ENT1, NOTCH3, and miR-21 Reliable Prognostic Biomarkers in Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Gemcitabine Monotherapy? by Jiraskova, Lucie, Ryska, Ales, Duintjer Tebbens, Erik Jurjen, Hornychova, Helena, Cecka, Filip, Staud, Frantisek, Cerveny, Lukas

    Published in Cancers
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: